Home DermalEase References

DermalEase References

  • Sandilands A, Sutherland C, Irvine AD, McLean WI. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122(9): 1285-94.
  • Gilaberte Y, Prieto-Torres L, Pastushenko I, Juarranz Á. Anatomy and function of the skin. In: Hamblin MR, Avci P, Prow TW, eds. Nanoscience in Dermatology. Academic Press, 2016: 1-14.
  • Kim JY, Dao H. Physiology, integument. In: StatPearls [Internet]: StatPearls Publishing, https://www.ncbi.nlm.nih.gov/books/NBK554386/ (accessed on 20th February 2024)
  • Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 2005; 6(4): 215-23.
  • Kottner J, Beeckman D, Vogt A, Blume-Peytavi U. Skin health and integrity. In: Gefen A, ed. Innovations and Emerging Technologies in Wound Care. Academic Press, 2020: 183-96.
  • Marsella R, Segarra S, Ahrens K, Alonso C, Ferrer L. Topical treatment with sphingolipids and glycosaminoglycans for canine atopic dermatitis. BMC Vet Res 2020; 16(1): 92.
  • Cerrato S, Ramió-Lluch L, Brazís P, Fondevila D, Segarra S, Puigdemont A. Effects of sphingolipid extracts on the morphological structure and lipid profile in an in vitro model of canine skin. Vet J 2016; 212(1): 58-64.
  • Torrent A, Montell E, Vergés J, et al. Dermial®: a new natural ingredient with anti-aging and regenerative properties for skin. FASEB J 2013; 27(1): 633.
  • Lee DH, Oh JH, Chung JH. Glycosaminoglycan and proteoglycan in skin aging. J Dermatol Sci 2016; 83(3): 174-81.
  • Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol 2012; 4(3): 253-8.
  • Gupta RC, Lall R, Srivastava A, Sinha A. Hyaluronic acid: molecular mechanisms and therapeutic trajectory. Front Vet Sci 2019; 6: 192.
  • Salwowska NM, Bebenek KA, Zadlo DA, Wcislo-Dziadecka  DL. Physiochemical properties and application of hyaluronic acid: a systematic review. J Cosmet Dermatol 2016; 15(4): 520-6.
  • Wang F, Garza LA, Kang S, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007; 143(2): 155-63.
  • Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol 2014; 62(2): 91-5.
  • Franco-Barraza J, Beacham DA, Amatangelo MD, Cukierman E. Preparation of extracellular matrices produced by cultured and primary fibroblasts. Curr Protoc Cell Biol 2016; 71(1): 10-19.
  • Thomsett LR. Structure of canine skin. Br Vet J 1986; 142(2): 116-23.
  • Huang J, Heng S, Zhang W, et al. Dermal extracellular matrix molecules in skin development, homeostasis, wound regeneration and diseases. Semin Cell Dev Biol 2022; 128: 137-44.
  • Sun B. The mechanics of fibrillar collagen extracellular matrix. Cell Rep Phys Sci 2021; 2(8).
  • Holleran WM, Takagi Y, Uchida Y. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 2006; 580(23): 5456-66.
  • Paliwal S, Fagien S, Sun X, et al. Skin extracellular matrix stimulation following injection of a hyaluronic acid–based dermal filler in a rat model. Plast Reconstr Surg 2014; 134(6): 1224-33.
  • Turlier V, Delalleau A, Casas C, et al. Association between collagen production and mechanical stretching in dermal extracellular matrix: in vivo effect of cross-linked hyaluronic acid filler. A randomised, placebo-controlled study. J Dermatol Sci 2013; 69(3): 187-94.
  • Kleuser B, Japtok L. Sphingolipids and inflammatory diseases of the skin. In: Gulbins E, Petrache I, eds. Sphingolipids in Disease. Vienna: Springer, 2013.
  • Cha J, He C, Zhao H, Dong Y, An I, An S. Intercellular and intracellular functions of ceramides and their metabolites in skin (Review). Int J Mol Med 2016; 38(1): 16-22.
  • Shimada K, Yoon JS, Yoshihara T, Iwasaki T, Nishifuji K. Increased transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis. Vet Dermatol 2009; 20(5-6): 541-6.